MarcusSidneyShakerMD
Allergy & Immunology • Lebanon, NHAsthma & Allergic Conditions
Associate Professor, Pediatrics, Geisel School of Medicine
Dr. Shaker is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1 Medical Center Dr
Lebanon, NH 03756Phone+1 603-653-9885
Education & Training
University of Virginia Medical CenterResidency, Pediatrics, 1998 - 2001
University of Virginia School of MedicineClass of 1998
Certifications & Licensure
NH State Medical License 2004 - 2026
VT State Medical License 2005 - 2026
DE State Medical License 2003 - 2005
MD State Medical License 2003 - 2005
VA State Medical License 1998 - 2004- American Board of Allergy and Immunology Allergy & Immunology
- American Board of Pediatrics Pediatrics
Awards, Honors, & Recognition
- Fellow (FAAP) American Academy of Pediatrics
- Fellow (FAAAAI) American Academy of Allergy Asthma and Immunology
Publications & Presentations
PubMed
- 138 citationsDrug allergy: A 2022 practice parameter update.David A Khan, Aleena Banerji, Kimberly G Blumenthal, Elizabeth J Phillips, Roland Solensky
The Journal of Allergy and Clinical Immunology. 2022-12-01 - 36 citationsThe COVID-19 pandemic: Adverse effects on the social determinants of health in children and families.Elissa M. Abrams, Matthew Greenhawt, Marcus Shaker, Andrew D. Pinto, Ian Sinha
Annals of Allergy, Asthma & Immunology. 2021-10-23 - 35 citationsThe Health and Economic Outcomes of Peanut Allergy Management Practices.Marcus Shaker, Matthew Greenhawt
The Journal of Allergy and Clinical Immunology. in Practice. 2018-11-01
Journal Articles
- Achieving the Quadruple Aim to Deliver Value-Based Allergy Care in an Ever-Evolving Healthcare SystemMatthew Greenhawt, Marcus S Shaker, Annals of Allergy, Asthma & Immunology
- Development and Acceptability of a Shared Decision-Making Tool for Commercial Peanut Allergy TherapiesMatthew Greenhawt, Marcus Shaker, Don A Bukstein, David M Fleischer, David R Stukus, Annals of Allergy, Asthma & Immunology
Authored Content
- Achieving the Quadruple Aim to Deliver Value-Based Allergy Care in an Ever-Evolving Healthcare SystemApril 2020
- Development and Acceptability of a Shared Decision-Making Tool for Commercial Peanut Allergy TherapiesFebruary 2020
- Engaging Patient Partners in State of the Art Allergy Care: Finding Balance When Discussing RiskFebruary 2020
- Significant Health Care Cost Associated with Peanut Allergy Diagnostic CodesJanuary 2020
- Join now to see all
Press Mentions
- Smiles Abound at AAAAI 2022March 7th, 2022
Original Article A Cost-Effectiveness Evaluation of Hospitalizations, Fatalities, and Economic Outcomes Associated with Universal Versus Anaphylaxis Risk-Stratified COVID-19 Vaccination StrategiesMarch 9th, 2021
Pediatricians Slow to Embrace Peanut Allergy Guidelines for InfantsJuly 17th, 2020- Join now to see all
Professional Memberships
- Fellow
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
